By BCM Investment Team Nearly a year has passed since Pfizer and BioNTech announced successful Phase 3 trial results for their groundbreaking mRNA-based Covid-19 vaccine. The effort to develop, produce, and distribute these vaccines has been one of the most impressive societal accomplishments in...